SCHEMBL6162964

SCHEMBL6162964

N#Cc1cccc(C[CH]C(=O)N2CCSC2C(N)=O)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 3/20 0.43
DPP4 P27487 2/20 0.43
FAP Q12884 1/20 0.43
DPP8 Q6V1X1 1/20 0.43
DPP9 Q86TI2 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
EPHX1 P07099 1/20 0.39
ADRA1D P25100 1/20 0.38
KCNH2 Q12809 1/20 0.38
MAPK8 P45983 1/20 0.37
FAAH O00519 1/20 0.36
MGLL Q99685 1/20 0.35
MEP1A Q16819 1/20 0.34
MEP1B Q16820 1/20 0.34
CCR3 P51677 2/20 0.34
HSD11B1 P28845 1/20 0.34
JAK2 O60674 2/20 0.34
JAK3 P52333 2/20 0.34
JAK1 P23458 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6163040 0.83 RIPK1 (0.36) DPP7DPP4DPP8DPP9SIRT1
SCHEMBL6167323 0.72 LMNA (0.44) SIRT2SIRT1CFD
SCHEMBL6350305 0.65 ACE (0.37) DPP7DPP4FAPDPP8DPP9
SCHEMBL3137610 0.65 CNR2 (0.39) DPP4
SCHEMBL30646949 0.64 GLA (0.51) MEP1AMEP1B
SCHEMBL253203 0.64 GLA (0.51) MEP1AMEP1B
SCHEMBL7419587 0.64 SIRT2 (0.51) DPP7DPP4FAPDPP8DPP9
SCHEMBL30489963 0.63 MAPK8 (0.56) SIRT2SIRT1EPHX1ADRA1DMAPK8
SCHEMBL6714339 0.63 MAPK8 (0.56) SIRT2SIRT1EPHX1ADRA1DMAPK8
SCHEMBL7419118 0.63 SIRT2 (0.55) DPP7DPP4FAPDPP8DPP9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1134213-B1 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER (US) 2005-11-02 EP disclosed
EP-0832065-B1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER (US) 2001-10-10 EP disclosed
EP-1134213-A2 Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides PFIZER INC. (US) 2001-09-19 EP disclosed
US-6277877-B1 GLYCOGEN PHOSPHORYLASE INHIBITOR; ANTIDIABETIC AGENTS PFIZER, INC. 2001-08-21 US disclosed
US-6107329-A HYPOTENSIVE AGENTS; CARDIOVASCULAR DISORDERS PFIZER, INC. (US) 2000-08-22 US disclosed
WO-1996039384-A1 SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS PFIZER, INC. (US) 1996-12-12 WO disclosed